8-KLeadership Changes

DEXCOM INC 8-K Report, Executive Changes (Mar 10, 2020)

Filed March 10, 2020For Securities:DXCM

Summary

DexCom, Inc. (DXCM) announced a key executive promotion and the establishment of a new management bonus plan in an 8-K filing dated March 10, 2020. The company promoted Jereme Sylvain to Senior Vice President, Finance and Chief Accounting Officer, effective March 9, 2020. This promotion signifies a strengthening of the finance and accounting leadership within the organization, with Mr. Sylvain taking on the crucial role of principal accounting officer. In conjunction with his promotion, Mr. Sylvain received an increase in his annual base salary to $330,000, a target annual cash performance bonus of 50% of his base salary, and a significant restricted stock unit (RSU) grant valued at $1,400,000. This compensation package, including the RSU award that vests over three years, reflects the company's confidence in his leadership and aligns his incentives with the long-term success of DexCom. Additionally, the company approved a new management bonus plan for fiscal 2020, outlining performance-based cash bonuses tied to company-wide financial and operational targets, including revenue/patient additions, EBITDA margin, and specific performance milestones. This plan aims to incentivize key management personnel by linking a portion of their compensation to the company's achievement of strategic goals.

Key Highlights

  • 1Jereme Sylvain promoted to Senior Vice President, Finance and Chief Accounting Officer, effective March 9, 2020.
  • 2Mr. Sylvain will serve as DexCom's principal accounting officer.
  • 3Mr. Sylvain's annual base salary increased to $330,000.
  • 4Mr. Sylvain is eligible for an annual cash performance bonus with a target of 50% of his base salary for 2020.
  • 5Mr. Sylvain received a $1,400,000 grant of restricted stock units (RSUs) vesting over three years.
  • 6DexCom approved a new management bonus plan for fiscal 2020 tied to company performance.
  • 7The bonus plan's payout is based on revenue/patient addition, EBITDA margin, and performance milestones, with potential for up to 200% of target bonus.

Frequently Asked Questions

Jereme Sylvain's promotion to Senior Vice President, Finance and Chief Accounting Officer signifies an elevation of his responsibilities within DexCom's financial leadership. He will now serve as the company's principal accounting officer, a critical role in ensuring accurate financial reporting and compliance with SEC regulations. His expanded role suggests the company's confidence in his ability to manage and oversee its financial operations at a higher executive level.

Following his promotion, Mr. Sylvain's compensation includes an annual base salary of $330,000. He is also eligible for an annual cash performance bonus with a target of 50% of his base salary for 2020. Furthermore, he received a substantial grant of $1,400,000 in restricted stock units (RSUs), which will vest in three equal annual installments, aligning his long-term financial interests with the company's stock performance.

The fiscal 2020 management bonus plan is tied to achieving specific company-wide performance targets. The bonus payout is determined by three components: 55% is based on revenue or new patient addition goals, 20% is based on achieving a targeted EBITDA margin, and 25% is based on achieving specified corporate performance milestones. The plan also includes provisions for 'stretch' performance milestones that could increase the overall payout.

The new management bonus plan allows for a maximum payout of up to 200% of an individual's target bonus. This maximum payout is contingent upon the company achieving specified levels across the Revenue/Patient Component, EBITDA Margin Component, and Performance Component, potentially enhanced by achieving additional 'stretch' performance milestones.